Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
May 5, 2020
Document Date
Apr 30, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
LEBWOHL DAVID